Federal Agencies Open Investigation Into the Safety of Abortion Drug Mifepristone ✅
The Health and Human Services and FDA are reviewing mifepristone following studies showing nearly 11% of patients reported serious adverse events after using the abortion pill.
- The Trump administration is reviewing safety protocols surrounding mifepristone amid restrictions from conservative states, as reported by the Hill.
- Robert F. Kennedy Jr. and FDA Commissioner Marty Makary stated that HHS may change the Risk Evaluation and Mitigation Strategy due to new studies questioning safety.
- Texas allows private citizens to sue anyone involved in abortion drug transactions for up to $100,000, exempting users of the pills.
- Attorney General Ken Paxton issued cease-and-desist letters to organizations for allegedly facilitating illegal abortion drug access in Texas.
63 Articles
63 Articles
Abortion drug review, Starbucks closures, tropical tango for hurricanes: Check out today’s news stories | News Channel 3-12
By Sarah Hutter, CNN Welcome to 5 Things PM! If you’re a parent or guardian, you’ve likely heard about the importance of respecting your children’s feelings. But to raise emotionally healthy kids, your mental health needs to matter, too. Here’s what else you might have missed during your busy day. 5 things 1⃣ Approved drug questioned The FDA is reviewing evidence about the safety and efficacy of mifepristone — used in medication abortion — to in…


FDA to Launch Review of Abortion Pill Safety
(MedPage Today) -- The Trump administration said it will review the medication abortion drug mifepristone (Mifeprex) to see whether current restrictions on its use are sufficient to keep patients safe. "Since its original approval, the FDA has...
Coverage Details
Bias Distribution
- 62% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium